HempNewsBreaks

FridayJan 14, 2022 12:50 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Deliver More Effective Oral Medicine

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing the effectiveness of orally administered drugs. With oral absorption being the most convenient and widely used route for taking medications, decades of research have advanced the understanding of critical factors controlling oral bioavailability. Scientists are now better understanding the physiological function and formulation functionality that has been used in designing improved and more desirable oral medicine delivery through extensive research. Lexaria is accomplishing this through its patented DehydraTECH(TM) technology. “DehydraTECH improves the way that active pharmaceutical ingredients (‘APIs’) make their way into the bloodstream. This is…

Continue Reading

FridayJan 14, 2022 12:32 pm

HempNewsBreaks – Marijuana Company of America Inc.’s (MCOA) Strong Financial Performance Reflects Successful Diversification Capabilities, Organic Growth

Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities as more states and countries worldwide push for the legalization of cannabis. MCOA offers diverse operations that include its cDistro distribution company, as well as hempsmart(TM) and VBF brands, a premium CBD company and a cannabis nursery cultivation facility in Salinas, California, respectively. In addition, the company is building its portfolio of investments and joint ventures, representing the highest standards of professionalism and integrity in the legal cannabis and industrial hemp markets. “MCOA recently reported a significant milestone, reaching the highest…

Continue Reading

ThursdayJan 13, 2022 3:05 pm

HempNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Strong Financial Results Evidence Continued Execution, Brands’ Impact on Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently released its unaudited financial results for the fiscal quarter ended Sept. 30, 2021. The company saw revenues increase by more than 1,000% to $1.1 million with a gross profit of $356,168, a significant turnaround from the loss of $40,280 recorded in Q3 2020. A recent article quotes BevCanna Chief Financial Officer John Campbell as saying, “As we closed out the third quarter, we delivered impressive revenue growth of more than 1,000%, achieving $1.1 million in sales, compared to $94,000 in the…

Continue Reading

FridayJan 07, 2022 1:18 pm

HempNewsBreaks – Marijuana Company of America Inc. (MCOA) Carving out Market Share, Tapping Strategic Partnerships

Marijuana Company of America (OTC: MCOA) recently released financial results for the three months ended Sept. 30, 2021 (“Q3 2021”), posting a 731% year-on-year increase compared to the same period in Q3 2020. Total revenue stood at $442,178 (up from $53,195), with gross profit to $63,687, up from $16,025 in Q3 2020, representing a 297% increase over that period. MCOA has attributed the impressive growth to its new acquisition of cDistro, a distribution enterprise, which positioned it to take advantage of immediate revenue granted by the opportunity to carve out a significant market share in the specialty distribution space. In…

Continue Reading

ThursdayJan 06, 2022 3:38 pm

HempNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Expands White-Label Program to Add Averi Health Products

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently entered into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products. An emerging alternative beverage company, Averi Health Products was founded by Terry Donnelly, former CEO of the award-winning Hill Street Beverage Co. Catering to millennials’ changing preferences, with many choosing to consume less alcohol than preceding generations, Averi is focused on creating cannabis and hemp-infused adult beverage options directed at consumers with a discerning palate, who are unwilling to compromise on taste, complexity, sophistication or social…

Continue Reading

TuesdayJan 04, 2022 2:27 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23…

Continue Reading

ThursdayDec 30, 2021 1:04 pm

HempNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Selected as Official Water Supplier of Summer 2022 Highlight Event

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race. The three-day Canadian E-Fest is slated to take place between June 30 to July 2, 2022, and will welcome the ABB FIA Formula E…

Continue Reading

ThursdayDec 23, 2021 1:05 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Building World-Class House of Brands

Flora Growth Corp. (NASDAQ: FLGC) recently signed a licensing agreement with Tonino Lamborghini that marked Flora Growth’s entry into the cannabis beverages market. Under the terms of the partnership, FLGC will produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia. The product line, which will be produced in Florida for initial sale in U.S. states where cannabidiol (“CBD”) ingestibles are legal, will contain CBD and other premium cannabinoids, including cannabigerol (“CBG”). Tonino Lamborghini is a luxury brand operating in the high-end designer products, hotel, beverage and real estate segments. “We are excited to partner with such a…

Continue Reading

ThursdayDec 23, 2021 12:35 pm

HempNewsBreaks – Marijuana Company of America Inc. (MCOA) Expanding Reach into New Regions, Leveraging Partnerships to Facilitate Growth

Marijuana Company of America (OTC: MCOA) has taken steps to extend its reach into new regions, including Latin America, and to leverage current strategic partnerships with several companies and its wholly owned subsidiaries to facilitate growth in an industry that continues to expand despite recent setbacks. Much like other industries around the world, the marijuana market was significantly impacted by the COVID-19 pandemic. The global cannabis market, which was valued at $22.1 billion in 2020, is expected to grow at a CAGR of 13.9% during the 2021 to 2026 forecast period. Companies that MCOA has partnered with include Cannabis Global…

Continue Reading

TuesdayDec 21, 2021 2:51 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Pursuing Regulatory Approvals for DehydraTECH(TM), Entry into Different Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study…

Continue Reading